Kanada - inglise - Health Canada

pharmascience inc - doxylamine succinate; pyridoxine hydrochloride - tablet (delayed-release) - 10mg; 10mg - doxylamine succinate 10mg; pyridoxine hydrochloride 10mg - miscellaneous antiemetics

Kanada - inglise - Health Canada

apotex inc - doxylamine succinate; pyridoxine hydrochloride - tablet (delayed-release) - 10mg; 10mg - doxylamine succinate 10mg; pyridoxine hydrochloride 10mg - miscellaneous antiemetics

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

granules india limited - doxylamine succinate (unii: v9bi9b5yi2) (doxylamine - unii:95qb77jkpl), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - doxylamine succinate 6.25 mg - pain reliever/fever reducer cough suppressant antihistamine nasal decongestant • temporarily relieves these symptoms due to cold and flu: sneezing itching of the nose, throat or watery eyes due to hay fever cough nasal congestion sinus congestion and pressure sore throat headache minor aches and pains runny nose • helps clear nasal passages and shrinks swollen membranes • temporarily reduces fever • with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. • if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric, or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

bryant ranch prepack - doxylamine succinate (unii: v9bi9b5yi2) (doxylamine - unii:95qb77jkpl), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.   limitations of use doxylamine succinate and pyridoxine hydrochloride delayed-release tablet has not been studied in women with hyperemesis gravidarum.   doxylamine succinate and pyridoxine hydrochloride is contraindicated in women with any of the following conditions:   - known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride or any inactive ingredient in the formulation monoamine oxidase (mao) inhibitors intensify and prolong the adverse central nervous system effects of doxylamine succinate and pyridoxine hydrochloride [see drug interactions (7.1)].  risk summary doxylamine succinate and pyridoxine hydrochloride is intended for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. maternal risks a

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - doxylamine succinate, quantity: 25 mg - tablet, uncoated - excipient ingredients: purified talc; microcrystalline cellulose; croscarmellose sodium; povidone; calcium hydrogen phosphate dihydrate; magnesium stearate; pregelatinised maize starch - temporary relief of sleeplessness.

Singapur - inglise - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - norethisterone - tablet - 5 mg - norethisterone 5 mg

Singapur - inglise - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - drospirenone; ethinylestradiol - tablet, film coated - 3 mg - drospirenone 3 mg; ethinylestradiol 0.03 mg

Iisrael - inglise - Ministry of Health

bayer israel ltd - cyproterone acetate - tablets - cyproterone acetate 10 mg - cyproterone - cyproterone - treatment of pronounced signs of virilisation in women, which make hormone therapy necessary:• severe forms of acne, when it is accompanied by inflammation and the formation of nodes (acne papulopustulosa, acne nodulocystica) or if there is a risk of scarring,• moderate to severe forms of hirsutism,• moderate to severe forms of androgenic alopecia.cyproterone acetate 10 mg is indicated for pronounced signes of virilisation in women, which make hormone therapy necessary if satisfactory results could not be obtained with medicinal products containing low-dose cyproterone or with other treatment options. when treating acne, hormone treatment should be weighed against systemic antibiotic treatment

Iisrael - inglise - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - film coated tablets - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations - - oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who choose to use an oral contraceptive as their method of birth control.- treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. - in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - cloquintocet-mexyl - unknown - cloquintocet-mexyl acetate active 0.0 - active constituent